Active Litigation
Marquet Cardiovascular EVH Device Facts
TorHoerman Law is investigating claims for the Marquet Cardiovascular EVH Device.
Active Litigation
TorHoerman Law is investigating claims for the Marquet Cardiovascular EVH Device.
On this page, we’ll discuss the Marquet Cardiovascular EVH Device Lawsuit Investigation, the recent recall of these devices, injuries related to the recall, and much more.
The Maquet Cardiovascular VasoView HemoPro Endoscopic Vessel Harvesting (EVH) Systems have been associated with reports of injuries due to device malfunctions.
Specifically, there is a risk of silicone detaching from the jaws of the harvesting tool during use, which can lead to device failure and the introduction of silicone debris into the patient.
This issue has resulted in procedural delays and, in some cases, the need to convert to more invasive open-vessel harvesting procedures.
According to reports, there have been 17 or more injuries linked to this problem, with at least three instances where the silicone debris could not be retrieved from the patient.
In response to these safety concerns, Getinge and its subsidiary Maquet Cardiovascular initiated a recall of the affected VasoView HemoPro 1 and 1.5 EVH Systems in September 2024.
The U.S. Food and Drug Administration (FDA) has classified this as a Class I recall, indicating a situation where there is a reasonable probability that the use of these products could cause serious adverse health consequences or death.
The FDA has also added EVH devices to its medical device shortage list, acknowledging that the removal of these products from the market may lead to supply disruptions.

Lawyers are investigating personal injury claims related to these devices.
If you or a loved one suffered injuries due to a recalled Marquet Cardiovascular EVH Device, reach out to a lawyer today for a free consultation.
Call TorHoerman Law, or use the chat feature on this page to get in touch with our lawyers.
In September 2024, Maquet Cardiovascular, a subsidiary of Getinge, initiated a recall of its VasoView HemoPro 1 and 1.5 Endoscopic Vessel Harvesting (EVH) Systems due to safety concerns.
The recall was prompted by reports of silicone detaching from the jaws of the harvesting tool during use, leading to device malfunction and the introduction of silicone debris into patients.
This issue has resulted in at least 17 serious injuries, including three cases where the silicone debris could not be retrieved.
The U.S. Food and Drug Administration (FDA) classified this as a Class I recall, indicating a situation where there is a reasonable probability that the use of these products could cause serious adverse health consequences or death.
Healthcare providers are advised to consider alternative devices and to exercise caution when using any EVH systems, inspecting them for signs of damage or silicone peeling prior to use.

Key Points of the Recall:
Patients and healthcare providers have reported several injuries linked to the malfunctioning Maquet Cardiovascular EVH devices.

These injuries include:
The Maquet Cardiovascular Endoscopic Vessel Harvesting (EVH) devices, like the VasoView HemoPro systems, are medical tools used during certain types of surgical procedures, particularly heart surgeries like coronary artery bypass grafting (CABG).
Coronary artery bypass grafting is often needed when the arteries supplying blood to the heart are blocked or severely narrowed due to conditions like coronary artery disease.
These tools are designed to harvest (remove) a healthy blood vessel, usually from the patient’s leg (saphenous vein) or arm (radial artery).
The harvested vessel is then used to create a bypass around blocked or damaged arteries in the heart.
This restores proper blood flow.

Instead of making large, open incisions to remove the vessel, surgeons use these devices to perform the procedure endoscopically, meaning through small cuts with the help of a camera.
The device includes a small, tube-like tool with a camera and cutting instruments, allowing for precise removal of the vessel while minimizing damage to surrounding tissues.
In essence, these tools make heart surgery less invasive and improve patient recovery, but recent malfunctions have raised safety concerns for both surgeons and patients.
TorHoerman Law is actively investigating claims of injuries linked to defective Maquet Cardiovascular EVH devices.
Reports of silicone detachment and device malfunctions during surgery have caused serious complications for patients, including prolonged recovery times and the need for additional procedures.
These issues stem from the recall of the VasoView HemoPro 1 and 1.5 systems, classified by the FDA as a Class I recall due to the potential for severe health consequences.
Our team is dedicated to helping individuals affected by these defective devices seek justice and compensation for their injuries.
With extensive experience in medical device litigation, we are ready to provide the support you need.

If you or a loved one suffered injuries from a recalled EVH device, contact TorHoerman Law today for a free consultation.
Call us now or use the chat feature on this page to get started.
The most commonly reported injuries include complications from silicone debris left in the body, such as inflammation, infection, and foreign body reactions.
Patients have also experienced prolonged recovery times and additional scarring when device malfunctions required surgeons to switch to more invasive open procedures.
The recall was initiated in September 2024 after reports of silicone detachment from the jaws of the VasoView HemoPro systems during surgery.
This malfunction posed risks of device failure, patient harm, and the introduction of silicone debris, which led the FDA to classify the recall as Class I, its most serious category.
If you were injured due to the malfunction of a Maquet Cardiovascular EVH device or suffered complications linked to its recall, you may be eligible to file a personal injury claim.
Eligibility typically depends on the extent of your injuries, medical documentation, and whether the device used in your procedure was part of the recall.
It’s important to contact an attorney to speak about your situation on an individual basis.
Call TorHoerman Law today for a free consultation.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.